scPharmaceuticals Inc.
NASDAQ:SCPH
4.32 (USD) • At close November 7, 2024
Overzicht | Financiële gegevens
Bedrijfsnaam | scPharmaceuticals Inc. |
Symbool | SCPH |
Munteenheid | USD |
Prijs | 4.32 |
Beurswaarde | 216,124,416 |
Dividendpercentage | 0% |
52-weken bereik | 3.24 - 6.71 |
Industrie | Biotechnology |
Sector | Healthcare |
CEO | Mr. John H. Tucker |
Website | https://www.scpharmaceuticals.com |
An error occurred while fetching data.
Over scPharmaceuticals Inc.
scPharmaceuticals Inc., a pharmaceutical company, engages in the development and commercialization of various pharmaceutical products. The company's lead product candidate is FUROSCIX that consists of formulation of furosemide, which is delivered through an on-body infusor for treatment of congestion in patients with heart failure. Its product pipeline also includes scCeftriaxone,
Vergelijkbare Aandelen
Financiële Gegevens
Cijfers zijn in miljoenen (USD)
Cijfers zijn in miljoenen (USD)